CNSX:IME

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Imagin Medical Inc., a surgical imaging company, focuses on advancing new methods of visualizing cancer during minimally invasive procedures. More Details


Snowflake Analysis

Adequate balance sheet with weak fundamentals.

Share Price & News

How has Imagin Medical's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: IME's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

-28.6%

IME

2.3%

CA Medical Equipment

-0.4%

CA Market


1 Year Return

-50.0%

IME

45.6%

CA Medical Equipment

-3.9%

CA Market

Return vs Industry: IME underperformed the Canadian Medical Equipment industry which returned 46.6% over the past year.

Return vs Market: IME underperformed the Canadian Market which returned -3.5% over the past year.


Shareholder returns

IMEIndustryMarket
7 Day-28.6%2.3%-0.4%
30 Day25.0%5.6%3.1%
90 Day-16.7%5.4%2.4%
1 Year-50.0%-50.0%45.6%45.6%-0.4%-3.9%
3 Year-86.1%-86.1%-51.3%-51.3%6.7%-3.8%
5 Yearn/a-75.5%-75.5%35.5%14.7%

Price Volatility Vs. Market

How volatile is Imagin Medical's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Imagin Medical undervalued compared to its fair value and its price relative to the market?

12.44x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate IME's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate IME's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: IME is unprofitable, so we can't compare its PE Ratio to the XN Medical Equipment industry average.

PE vs Market: IME is unprofitable, so we can't compare its PE Ratio to the Canadian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate IME's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: IME is overvalued based on its PB Ratio (12.4x) compared to the CA Medical Equipment industry average (5.6x).


Next Steps

Future Growth

How is Imagin Medical forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

26.0%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Imagin Medical has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Imagin Medical performed over the past 5 years?

-30.2%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: IME is currently unprofitable.

Growing Profit Margin: IME is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: IME is unprofitable, and losses have increased over the past 5 years at a rate of 30.2% per year.

Accelerating Growth: Unable to compare IME's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: IME is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (1.8%).


Return on Equity

High ROE: IME has a negative Return on Equity (-1397.05%), as it is currently unprofitable.


Next Steps

Financial Health

How is Imagin Medical's financial position?


Financial Position Analysis

Short Term Liabilities: IME's short term assets (CA$350.3K) exceed its short term liabilities (CA$152.4K).

Long Term Liabilities: IME has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: IME is debt free.

Reducing Debt: IME had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: IME has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: IME has less than a year of cash runway if free cash flow continues to reduce at historical rates of 39% each year


Next Steps

Dividend

What is Imagin Medical current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate IME's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate IME's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if IME's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if IME's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of IME's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.0yrs

Average board tenure


CEO

Jim Hutchens

4.67yrs

Tenure

CA$649,099

Compensation

Mr. Edward James Hutchens, also known as Jim, is the Co-founder and Managing Director of Origin Partners. Mr. Hutchens has been Chief Executive Officer and President of Imagin Medical Inc. since February 2 ...


CEO Compensation Analysis

Compensation vs Market: Jim's total compensation ($USD494.43K) is above average for companies of similar size in the Canadian market ($USD171.79K).

Compensation vs Earnings: Jim's compensation has been consistent with company performance over the past year.


Board Members

NamePositionTenureCompensationOwnership
Edward Hutchens
CEO, President & Director4.67yrsCA$649.10k4.66%
CA$ 207.7k
John Vacha
CFO, Corporate Secretary & Director2.75yrsCA$338.86k0.22%
CA$ 9.7k
Christopher Bleck
Independent Director2yrsCA$6.00k0.16%
CA$ 7.0k
Ralph de Vere White
Chairman of Scientific Medical Advisory Board4.5yrsno datano data
Edward Messing
Member of Scientific Medical Advisory Board4.08yrsno datano data
Ashish Kamat
Member of Scientific Advisory Board1.5yrsno datano data
Robin Atlas
Independent Chairperson of the Boardno dataCA$6.00k0.59%
CA$ 26.4k
Kenneth Daignault
Independent Director4.08yrsCA$71.85k0.16%
CA$ 6.9k
Liam Hurley
Member of Scientific Medical Advisory Board4yrsno datano data
Roger Buckley
Member of Scientific Medical Advisory Board3.92yrsno datano data

4.0yrs

Average Tenure

Experienced Board: IME's board of directors are considered experienced (4 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: IME insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 28.2%.


Top Shareholders

Company Information

Imagin Medical Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Imagin Medical Inc.
  • Ticker: IME
  • Exchange: CNSX
  • Founded:
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: CA$4.459m
  • Shares outstanding: 178.34m
  • Website: https://imaginmedical.com

Location

  • Imagin Medical Inc.
  • 890 West Pender Street
  • Suite 600
  • Vancouver
  • British Columbia
  • V6C 1L9
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
DPD2DB (Deutsche Boerse AG)YesCommon SharesDEEURFeb 2016
IMEX.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDFeb 2016
IMECNSX (Canadian National Stock Exchange)YesCommon SharesCACADFeb 2016

Biography

Imagin Medical Inc., a surgical imaging company, focuses on advancing new methods of visualizing cancer during minimally invasive procedures. Its i/Blue Imaging System with its proprietary optics and light ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/10/24 01:02
End of Day Share Price2020/10/23 00:00
Earnings2020/06/30
Annual Earnings2019/09/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.